P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung

作者：H.R. Kim, C. Gridelli, D. Kapur, A. Tufman, E. Félip, V. Velcheti, Yuchan Kim, T.O. Goetze, P. Garrido Lopez, R. Corre, K. Penkov, Raushan Anjum, Brittany Pace, W. Liu, T. Borgovan, D. Ledger, J. Carver, A. Waszak, A. Dhar, S. Novello · 发表于：Journal of Thoracic Oncology · 年份：2022 · DOI：10.1016/j.jtho.2022.07.183 · 被引用次数：8 · 研究领域：Cancer Immunotherapy and Biomarkers、Colorectal Cancer Treatments and Studies、CAR-T cell therapy research